WALTHAM, Massachusetts–(BUSINESS WIRE)–Avedro, Inc., une société de produits pharmaceutiques ophtalmiques et d’appareils médicaux qui est aussi le leader mondial du remodelage de la cornée, a annoncé aujourd’hui avoir démarré le recrutement de patients dans le cadre d’un essai clinique pivot de Phase 3 visant à évaluer l’innocuité et l’efficacité d’un procédé de réticulation du collagène de la cornée épithélium-on (épi-on) pour traiter les patients atteints d’un kératocône progressif. Le kéra
Author: Business Wire
Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus
WALTHAM, Mass.–(BUSINESS WIRE)–#crosslinking–Avedro, Inc., an ophthalmic pharmaceutical and medical device company and the world leader in corneal remodeling, today announced that it has begun enrolling patients in a pivotal Phase 3 clinical trial t…
Aerie Pharmaceuticals Announces Appointment of William Coppola as Intellectual Property Counsel
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of William Coppola as Intellectual Property Counsel, reporting to John LaRocca, Aerie’s General Counsel. Mr. Coppola will oversee intellectual property matters both domestically and
Aura Biosciences Announces Update of Clinical Safety and Efficacy Data on Lead Candidate AU-011 for Choroidal Melanoma
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences announces new interim data from Phase 1b/2 study of light-activated AU-011 for the treatment of primary choroidal melanoma.
Global Ophthalmic Ultrasound Systems Market Outlook 2017-2026, With an Expected CAGR of 8% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Ultrasound Systems – Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering. According to the publisher, the Global Ophthalmic Ultrasound Systems Market is accounted for $2…
Cataract Surgery Devices: Global Market Report 2018-2023 – Market is Projected to Reach $9 Billion – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Cataract Surgery Devices Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. Cataract Surgery Devices Market was valued at $7 billion in 2016, and is estimated to reach $9 billio…
Cataract Surgery Devices: Global Market Report 2018-2023 – Market is Projected to Reach $9 Billion – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Cataract Surgery Devices Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. Cataract Surgery Devices Market was valued at $7 billion in 2016, and is estimated to reach $9 billio…
Mevion Medical Systems Successfully Completes Growth Financing; Well Positioned for Global Expansion
LITTLETON, Mass.–(BUSINESS WIRE)–#cancercare–Mevion Medical Systems has successfully completed growth financing for global expansion.
Optovue Announces Expanded FDA Clearance of Epithelial Thickness Mapping
FREMONT, Calif.–(BUSINESS WIRE)–Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA), today announced an expanded FDA 510(k) clearance for non-contact, quantitative measurements of the epithel…
Health and Eye Care Industry Leader Philip Isham Joins Eye Health America as Chief Development Officer
ATLANTA–(BUSINESS WIRE)–Eye Health America (EHA), the leader in full-service eye care, has named Philip Isham, eye care strategist and executive, as Chief Development Officer
Tilak Announces CE Marking for Odysight, Its First Mobile Medical Game in Ophthalmology
PARIS–(BUSINESS WIRE)–Tilak, a company from the iBionext network developing mobile medical applications for the management of chronic diseases, announced that Odysight, its first mobile medical game dedicated to the monitoring of patients with chroni…
Ocular Hypertension Drug Development Pipeline Study, H1 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Hypertension: Drug Development Pipeline Study, H1 2018” report has been added to ResearchAndMarkets.com’s offering. Ocular Hypertension report identifies aspects important in modifying industry market scenarios, inc…
Ocular Hypertension Drug Development Pipeline Study, H1 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Hypertension: Drug Development Pipeline Study, H1 2018” report has been added to ResearchAndMarkets.com’s offering. Ocular Hypertension report identifies aspects important in modifying industry market scenarios, inc…
Global Ophthalmic Drugs Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 5.3% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Drugs Market by Indication, Type, Dosage Form, Technology, Distribution Channel, and Therapeutic Class – Global Opportunity Analysis and Industry Forecast, 2017-2023” report has been added to ResearchAndMarkets….
CMS Issues Preliminary Decision on Unique J Code for Avedro Photrexa® Drug Formulations
WALTHAM, Mass.–(BUSINESS WIRE)–Avedro, Inc., an ophthalmic pharmaceutical and medical device company and world leader in corneal remodeling, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a preliminary decision to establish a product specific Healthcare Common Procedure Coding System (HCPCS) J code for Photrexa® drug formulations. Claims submitted with a product specific J code are generally processed more efficiently than claims using a miscellaneous cod
Ocular Therapeutix™ to Present at the 2018 JMP Securities Life Sciences Conference
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Anton…
Optovue Receives FDA Clearance for AngioAnalytics – the World’s First OCT Angiography Metrics
FREMONT, Calif.–(BUSINESS WIRE)–#AngioAnalytics–Optovue announces FDA clearance of AngioAnalytics, the first optical coherence tomography angiography (OCTA) blood vessel measurement technology.
Global Glaucoma Surgery Devices Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 29.3% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Glaucoma Surgery Devices Market by Surgery Type – Global Opportunity Analysis and Industry Forecast, 2017-2023” report has been added to ResearchAndMarkets.com’s offering. The global glaucoma surgery devices market was val…
Global Cataract Surgery Devices Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 4.3% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Devices Market by Product – Global Opportunity Analysis and Industry Forecast, 2017-2023” report has been added to ResearchAndMarkets.com’s offering. The global cataract surgery devices market was valued a…
EyeSouth Establishes a Presence in South Georgia and North Florida Through a Strategic Partnership with South Georgia / North Florida Eye Partners
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed a strategic partnership with South Georgia / North Florida Eye Partners and Cataract and Laser Surgery Center of South Georgia (“South Georgia Eye”), expanding its presence into the South Georgia and North Florida regions. EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a leading lower middle market healthcare private equity fir